More is better: combination therapies for myelodysplastic syndromes.
about
Spotlight on decitabine for myelodysplastic syndromes in Chinese patientsThe clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes.Epigenetic regulation of miRNA-124 and multiple downstream targets is associated with treatment response in myeloid malignanciesMultipotent adult progenitor cells improve the hematopoietic function in myelodysplasia.
P2860
More is better: combination therapies for myelodysplastic syndromes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
More is better: combination therapies for myelodysplastic syndromes.
@en
type
label
More is better: combination therapies for myelodysplastic syndromes.
@en
prefLabel
More is better: combination therapies for myelodysplastic syndromes.
@en
P1476
More is better: combination therapies for myelodysplastic syndromes
@en
P2093
Mikkael A Sekeres
Sudipto Mukherjee
P356
10.1016/J.BEHA.2014.11.002
P577
2014-11-11T00:00:00Z